Indications And Dose
Dyspepsia ▶BY MOUTH ▶Child 8–11 years: 5 mL, to be taken between meals and at bedtime ▶Child 12–17 years: 10 mL, to be taken between meals and at bedtime ▶Adult: 10 mL, to be taken between meals and at bedtime
PDF page 97
Drug reference
Dyspepsia ▶BY MOUTH ▶Child 8–11 years: 5 mL, to be taken between meals and at bedtime ▶Child 12–17 years: 10 mL, to be taken between meals and at bedtime ▶Adult: 10 mL, to be taken between meals and at bedtime
PDF page 97
Infants. neonates CONTRA-INDICATIONS, FURTHER INFORMATION ▶Aluminium-containing antacids Aluminium-containing antacids should not be used in neonates and infants because accumulation may lead to increased plasma- aluminium concentrations.
PDF page 97
Altacite Plus ® is low in Na+.
PDF page 97
▶In adults There is a risk of accumulation and aluminium toxicity with antacids containing aluminium salts. Absorption of aluminium from aluminium salts is increased by citrates, which are contained in many effervescent preparations (such as effervescent analgesics). ▶In children Aluminium-containing antacids should not be used in children with renal impairment, because accumulation may lead to increased plasma-aluminium concentrations. Dose adjustments Antacids containing magnesium salts should be avoided or used at a reduced dose because there is an increased risk of toxicity.
PDF page 97
There can be variation in the licensing of different medicines containing the same drug. Oral suspension ▶Altacite Plus (Peckforton Pharmaceuticals Ltd) Simeticone 25 mg per 1 ml, Hydrotalcite 100 mg per 1 ml Altacite Plus oral suspension sugar-free | 100 ml p £4.00 sugar-free | 500 ml p £5.20 DT = £5.20
PDF page 97
10 mL, to be taken between meals and at
First-line fragment. Read the complete Indications and Dose section above.
PDF page 97